Cycurion, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cycurion, Inc. on March 17, 2026, regarding events occurring on March 19, 2026. The report details the results of a Special Meeting of Stockholders held to vote on proposals related to the exercise of common stock purchase warrants issued during a private placement that closed on December 5, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
As of the record date on January 21, 2026, the company had 5,148,411 shares of Voting Stock outstanding (4,188,187 Common Stock and 960,224 Preferred Voting Stock). A total of 2,611,518 shares were represented at the Special Meeting. Stockholders approved two key proposals:
- Proposal 1 (Warrant Exercise Proposal): Approved the issuance of up to 3,314,920 shares of Common Stock upon the exercise of warrants. This issuance may exceed 20% of outstanding shares, requiring approval under Nasdaq Listing Rule 5635(d).
- Votes For: 2,359,348
- Votes Against: 164,438
- Abstain: 5,773
- Non-Votes: 81,959
- Proposal 2 (Adjournment Proposal): Approved the ability to adjourn the meeting to solicit further proxies if necessary.
- Votes For: 2,460,423
- Votes Against: 143,588
- Abstain: 7,207
- Non-Votes: 0
Guidance, Outlook, and Risks
The filing references a press release issued on March 17, 2026 (Exhibit 99.1), but the text of the press release is not included in this document. Consequently, specific management commentary, future guidance, or detailed risk factors regarding the warrant exercise are not available in the provided text. The primary contingency addressed was the potential need for additional proxy solicitation, which was authorized via the Adjournment Proposal.
Investor Verification Checklist
- Verify the exact number of warrants exercised and the resulting dilution to existing shareholders following the approval of Proposal 1.
- Review the full text of the press release (Exhibit 99.1) for management's strategic rationale regarding the warrant exercise.
- Confirm the current trading price of the common stock (CYCU) and warrants (CYCUW) to assess the economic impact of the 3,314,920 potential new shares.
- Check subsequent filings for the actual issuance date and settlement of the warrant exercises.